| 000 | 01909 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250515010650.0 | ||
| 264 | 0 | _c20060425 | |
| 008 | 200604s 0 0 eng d | ||
| 022 | _a0009-9236 | ||
| 024 | 7 |
_a10.1016/j.clpt.2005.08.021 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLandau, Ruth | |
| 245 | 0 | 0 |
_aArg16 homozygosity of the beta2-adrenergic receptor improves the outcome after beta2-agonist tocolysis for preterm labor. _h[electronic resource] |
| 260 |
_bClinical pharmacology and therapeutics _cDec 2005 |
||
| 300 |
_a656-63 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdrenergic beta-2 Receptor Agonists |
| 650 | 0 | 4 |
_aAdrenergic beta-Agonists _xadministration & dosage |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAlleles |
| 650 | 0 | 4 |
_aAmino Acid Substitution _xgenetics |
| 650 | 0 | 4 |
_aArginine _xgenetics |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGene Frequency |
| 650 | 0 | 4 |
_aGlycine _xgenetics |
| 650 | 0 | 4 | _aHaplotypes |
| 650 | 0 | 4 |
_aHexoprenaline _xadministration & dosage |
| 650 | 0 | 4 | _aHomozygote |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant, Low Birth Weight |
| 650 | 0 | 4 | _aInfant, Newborn |
| 650 | 0 | 4 |
_aObstetric Labor, Premature _xgenetics |
| 650 | 0 | 4 | _aPregnancy |
| 650 | 0 | 4 | _aPregnancy Outcome |
| 650 | 0 | 4 |
_aReceptors, Adrenergic, beta-2 _xgenetics |
| 650 | 0 | 4 |
_aRespiratory Distress Syndrome, Newborn _xgenetics |
| 650 | 0 | 4 |
_aTachycardia _xgenetics |
| 650 | 0 | 4 |
_aTocolysis _xmethods |
| 650 | 0 | 4 |
_aTocolytic Agents _xadministration & dosage |
| 700 | 1 | _aMorales, Michel A | |
| 700 | 1 | _aAntonarakis, Stylianos E | |
| 700 | 1 | _aBlouin, Jean-Louis | |
| 700 | 1 | _aSmiley, Richard M | |
| 773 | 0 |
_tClinical pharmacology and therapeutics _gvol. 78 _gno. 6 _gp. 656-63 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.clpt.2005.08.021 _zAvailable from publisher's website |
| 999 |
_c15959450 _d15959450 |
||